ValuentumAd

Official PayPal Seal













Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Mar 22, 2018
AbbVie’s Product Concentration Risk Intensifies; Shares Yield ~3.9%
AbbVie will not seek accelerated approval for what had been expected to be its next blockbuster drug, Rova-T, which had been investigated for third-line relapsed/refractory small cell lung cancer. The market is reacting negatively to the disappointment.
Mar 21, 2018
General Mills' Dividend Is Now of Questionable Health
General Mills is stuck between a rock and a hard place, and the market is finally noticing. Its best dividend growth years have been behind it, but its recent dealings have put it in a rather precarious position heading into the next recession, the timing of which is the only uncertainty. The company has never been a consideration for inclusion in the simulated Dividend Growth Newsletter portfolio.
Mar 21, 2018
Our Reports on Stocks in the Biotech Industry
Image Source: Celgene. This listing has been discontinued. Please see our reports on pharmaceutical stocks.
Mar 20, 2018
Avoiding Troubled Equities Such as General Electric
The Valuentum process waits for a stock’s price to be moving higher before it is considered. The stock must not only be undervalued on both a discounted cash-flow basis and relative value basis, in our view, but the market must also believe that its true intrinsic value should be higher, too, as evidenced by a rising share price. The process is symmetrical. We also would wait for a company’s share price to break down before we may consider removing an overpriced stock. In some cases, the information contained in prices can even provide clues when to remove an underpriced stock, as in the case of General Electric.
Mar 20, 2018
Market Overreacts to Oracle’s Cloud Outlook
Image Shown: The performance of Oracle since the March 2009 bottom. Oracle reported in-line fiscal third-quarter results March 19, but its outlook for cloud revenues came in just a bit short relative to consensus expectations. The market seems to be overreacting.
Mar 19, 2018
Market Overreacts to Facebook News
Image Source: Christopher. The headline news seems concerning, but we’re taking a long-term perspective with Facebook. We doubt the news will meaningfully impact the trajectory of growth of its long-term free cash flow, and we’re not reading too much into events that seem heavily-influenced by the overheated political environment.
Mar 16, 2018
Saying Good Bye to Boeing…For Now
There probably hasn’t been a better large-cap call in the Dow Jones Industrial Average than Boeing during the past couple years, and we have been all over it. But shares have now “rolled over,” and its valuation isn’t as attractive as it once was, both dynamics pointing to reasons for removal from the simulated Dividend Growth Newsletter portfolio. We continue to peruse our coverage universe for an adequate dividend growth replacement.
Mar 16, 2018
Dividend Increases/Decreases for the Week Ending March 16
Let's take a look at companies that raised/lowered their dividend this week.
Mar 15, 2018
Dollar General: A Model of Consistency
Dollar General’s fiscal 2017 marked its 28th consecutive year of positive same-store sales growth, and we couldn’t be more impressed with the consistency of its operational performance in the past three decades, as well as its share price performance since its addition to the simulated Best Ideas Newsletter portfolio.
Mar 15, 2018
Nearly 60 Distribution Cuts Later, We Maintain Our View on the Hazards of the MLP Business Model
Image Source: Brian Cantoni. Valuentum has been highlighting the inherent risks associated with the master limited partnership (MLP) structure for some time now, but we are not alone in acknowledging the limited sustainability of such structures. Internal simplification transactions may only become more common moving forward as management teams seek to optimize the structure of their entities.


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.